Corrigendum to “Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury”

---

In the article titled “Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury” [1], it was identified that the beta-actin panels in Figures 4(a), 4(b), and 4(c) were identical. With the agreement of the editor, a revised version of Figure 4 is being provided with the data from a repeat of the experiment. The authors apologize for this error in the original publication. The corrected version of figure 4 is shown as Figure 1.

Figure 1 

Effect of KMP on MAPKs protein expressions. (a) ERK1/ERK2, p-ERK1/ERK2; (b) JNK, p-JNK; (c) p38, p-p38; and (d) NFκBp65. Data are expressed as normal intensity (% control). All the values are expressed as mean ± SEM; per group. versus sham; ^#; ^##; and ^### versus IR-control.